arrow
C

Camilo Jiménez

ut md anderson cancer center
H指数:54
被引数:9,165

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

OC7.2 - ECE_1828 - Safety of biopsy in pheochromocytoma/paraganglioma: a multicentre cohort study

OC7.2 - ECE_1828 - 肾上腺嗜铬细胞瘤/副神经节瘤活检的安全性:一项多中心队列研究

2026-08-100
OAAI
Belzutifan for Advanced Pheochromocytoma or Paraganglioma

Jimenez C, Andreassen M, Durand A, Moog S, Hendifar A, Welin S, 等人. LITESPARK-015 研究者团队. 贝zutifan治疗晚期嗜铬细胞瘤或副神经节瘤。新英格兰医学杂志。(2025)。doi: 10.1056/NEJMoa2504964

2025-10-014
PRE
Author Correction: International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents

作者更正:儿童和青少年嗜铬细胞瘤和副神经节瘤的诊断和管理国际共识声明

2025-08-130
PRE
Adverse skeletal related events in patients with bone-metastatic pheochromocytoma/paraganglioma
2024-09-012
PRE
International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents (Aug, 10.1038/s41574-024-01024-5, 2024)
2024-08-270
OA
International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents

儿童和青少年嗜铬细胞瘤和副神经节瘤诊断和治疗的国际共识声明

2024-08-151
OA
EO2401 (E) peptide immunotherapy plus nivolumab (N) in adrenocortical carcinoma (ACC) and metastatic pheochromocytoma/paraganglioma (MPP): EOADR1-19/SPENCER
2023-10-011
OA